KEI Seminars on Drug Pricing: 30 April 2015, Prof. Paul Grootendorst on the Canadian approach to drug pricing

On Thursday, 30 April 2015, KEI will host the first talk in a series of seminars on drug pricing. The seminars will take place via video conference (hosted by KEI), and participation is welcome either by attending the presentation at KEI’s Washington, DC offices, or to the extent we are able, joining the digital conference.

At present, we can add up to 15 persons on the digital conference. If there is a capacity issue for the remote participation, we will give priority to academics, government officials, NGOs working on drug pricing, and third party payers, and we will also explore other ways to expand the number of people who can listen in or participate in real time.

After each seminar, the entire discussion will be posted online via YouTube and will be available to the public for research and reference purposes.

This first talk will feature Professor Paul Grootendorst, the Director of the Division of Social and Administrative Pharmacy at the University of Toronto. Professor Paul Grootendorst will deliver a 15 minute talk on the Canadian approach to drug pricing before opening up the discussion to questions from those participating in the video conference. The seminars are intended to inform the debate surrounding high priced medicines and to encourage discussions about drug pricing solutions that can be applied here in the US.

The seminar featuring Professor Grootendorst will take place on Thursday 30 April 2015, at 10:00am EST.

If you would like to view the conference live through google hangout or participate in the discussion alongside our staff in the DC office, please fill out this Google Poll ( Please contact Elizabeth Rajasingh via elizabeth.rajasingh[at] with any questions. She will send out the link to join the seminar on the morning of the event.

Paul Grootendorst

Paul Grootendorst is the Director of the Division of Social and Administrative Pharmacy in the Leslie Dan Faculty of Pharmacy at the University of Toronto. He is also an associate professor in the Faculty of Pharmacy and the School of Public Policy and Governance at the University of Toronto and an adjunct associate professor in the Department of Economics at McMaster University. Paul is also an associate editor of Health Economics.

He researches the effects of changes in financing health care and remuneration of health care providers on the behaviour of consumers and producers in the healthcare system. He is interested in interactions between brand and generic drug firms and is currently working on an evaluation of the system of reference pricing of anti-hypertensive and nitrate medicines introduced in British Columbia; and effects of patient cost sharing for prescription medicines on use of drugs and other health services using both administrative health claims and health survey data; effects of patent term extension on R&D activity and drug expenditures; and effects of physician expenditure caps on physician labour supply and service patterns
Link to personal page: